California State Teachers Retirement System (CalSTRS)’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,533
Closed -$71.4K 3075
2023
Q4
$71.4K Sell
4,533
-1,544
-25% -$14.9K ﹤0.01% 2520
2023
Q3
$47.1K Sell
6,077
-3,085
-34% -$25.6K ﹤0.01% 2740
2023
Q2
$91K Buy
9,162
+898
+11% +$7.19K ﹤0.01% 2680
2023
Q1
$47.9K Sell
8,264
-731
-8% -$6.32K ﹤0.01% 2856
2022
Q4
$71.4K Buy
8,995
+221
+3% +$949 ﹤0.01% 2852
2022
Q3
$28K Sell
8,774
-731
-8% -$4.57K ﹤0.01% 3045
2022
Q2
$54K Sell
9,505
-13,091
-58% -$102K ﹤0.01% 3017
2022
Q1
$159K Buy
22,596
+5,272
+30% +$82.9K ﹤0.01% 2723
2021
Q4
$396K Buy
17,324
+10,096
+140% +$261K ﹤0.01% 2591
2021
Q3
$214K Buy
+7,228
New +$245K ﹤0.01% 2717

California State Teachers Retirement System (CalSTRS)'s ICVX Position: Q1 2024 in Review

California State Teachers Retirement System (CalSTRS) sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 4,533 shares — an estimated $71.4K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $396K in Q4 2021. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 4,533 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $71.4K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Icosavax, Inc. Common Stock position peaked at $396K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2024, filed 16 May 2024.